betapharm offered 8 products by AOK

Indian generic drug giant Dr Reddy's Laboratories says that betapharm AG, its wholly-owned German subsidiary, has been tentatively offered eight products in different regions of Germany covering people insured by the Allgemeine Ortskrankenkassen.

The tender procedure is yet to be concluded and is expected to face potential legal objections by several companies. On signing the final contracts with the AOK, which covers over 36% of the country's population, betapharm will be the sole supplier for AOK-insured persons for the products.

VS Vasudevan, president of Dr Reddy's European operations, said: "the preliminary results of the AOK tender establish betapharm's competitiveness in the tender segment of the market in Germany. For the eight products offered, we expect a significant increase in volume though at relatively lesser margins and for the balance [of the] portfolio, we expect the competitive intensity to continue."